Opening book details…
About this Medicine article
Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study by Steven Boonen; Roman S. Lorenc; Dietrich Wenderoth; Karen J. Stoner; Rachelle Eusebio; Eric S. Orwoll is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Steven Boonen; Roman S. Lorenc; Dietrich Wenderoth; Karen J. Stoner; Rachelle Eusebio; Eric S. Orwoll
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 8756-3282)
- Published
- 2012
- Field
- Medicine (Health Sciences)